Clinical Trials Browser

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Hodgkin Disease, Neoplasms

Hodgkin Disease

Hodgkin Disease, Lymphoma

Hodgkin Disease

Hodgkin Disease

Hodgkin Disease

Hodgkin Disease, Lymphoma

Hodgkin Disease, Lymphoma

Hodgkin Disease, Lymphoma

Hodgkin Disease, Lymphoma

Hodgkin Disease

Hodgkin Disease

Hodgkin Disease, Lymphoma

Hodgkin Disease

Hodgkin Disease

Hodgkin Disease, Lymphoma

Hodgkin Disease, Lymphoma

Hodgkin Disease

Hodgkin Disease, Lymphoma, HIV Infections

Hodgkin Disease

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections

Acquired Immunodeficiency Syndrome, Lymphoma, Lymphoma, Non-Hodgkin, HIV Infections

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, Nervous System Neoplasms, HIV Infections

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Hodgkin Disease, HIV Infections

Hodgkin Disease

Hodgkin Disease

Hodgkin Disease, Lymphoma

Lymphoma, Lymphoma, Follicular

Hodgkin Disease

Hodgkin Disease, Lymphoma

Hodgkin Disease

Hodgkin Disease

Hodgkin Disease

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Hodgkin Disease, Lymphoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse

Lymphoma, T-Cell, Peripheral

Hodgkin Disease, Lymphoma

Disease, Lymphoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Hodgkin Disease, Lymphoma

Hodgkin Disease, Lymphoma

Hodgkin Disease

Hodgkin Disease

Hematologic Diseases, Hodgkin Disease, Lymphoma

Clinical Trials

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

RADAR

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

MK-3475-667

A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

FIL Study on ABVD DD-DI as Upfront Therapy in HL.

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

HL-Russia-1

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

TXCH-HD-12A

Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

BREACH

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma

BRAPP2

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

HD16

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease

HD17 for Intermediate Stage Hodgkin Lymphoma

(Optimist)

Combination Chemotherapy in Treating Patients With Lymphoma

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma

R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma

Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma

GAINED

Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma

R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma

A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma